The VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction: An Overview
Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents. The syndrome is characterized by redness, swelling, pain, and tingling in the palms of the hands and the soles of the feet.
Callus-like thickened tender blisters with some surrounding erythema are most typically localized to areas of pressure or friction, such as the heel and forefoot. The National Cancer Institute has classified the clinical manifestations by grades, ranging from 1 to 3.
As per the article by Fischer et al. (2013) titled “The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysis”, a total of 984 patients from six clinical trials were available for analysis. The reported incidences of all-grade HFSR ranged between 7.7 % and 75.0 %.
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Epidemiology Segmentation
-
Total Cases of VEGFR Inhibitor-induced hand-foot skin reaction
-
Treatable Cases of VEGFR Inhibitor-induced hand-foot skin reaction
-
Total number of cases on VEGFR Inhibitors by Cancer Type
-
Grade-specific cases of VEGFR Inhibitor-induced hand-foot skin reaction
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market or expected to get launched during the study period. The analysis covers VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/vegfr-inhibitor-induced-hand-foot-skin-reaction-market
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Therapeutics Analysis
The VEGFR Inhibitor-induced hand-foot skin reaction market dynamics is anticipated to change in the coming years owing to the improvement in the rise in the number of healthcare spending across the world.
Some of the key companies in the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market include:
-
OnQuality
-
Takeda
-
Sinorda Biomedicine
And others
VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Therapies covered in the report include:
-
OQL011
-
Topical Tazarotene
And many more
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/vegfr-inhibitor-induced-hand-foot-skin-reaction-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Competitive Intelligence Analysis
4. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market Overview at a Glance
5. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Disease Background and Overview
6. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Patient Journey
7. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Epidemiology and Patient Population
8. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Treatment Algorithm, Current Treatment, and Medical Practices
9. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Unmet Needs
10. Key Endpoints of VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Treatment
11. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Marketed Products
12. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Emerging Therapies
13. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Seven Major Market Analysis
14. Attribute Analysis
15. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market Outlook (7 major markets)
16. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Access and Reimbursement Overview
17. KOL Views on the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market.
18. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market Drivers
19. VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/vegfr-inhibitor-induced-hand-foot-skin-reaction-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Healthcare Reports by DelveInsight
Fetal Monitoring Devices Market
“Fetal Monitoring Devices Market” report delivers an in-depth understanding of Fetal Monitoring Devices as well as the historical and forecasted market trends globally, which comprises North America, Europe, APAC, and RoW.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/